InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,297.10
(
-0.21%
)
US TECH 100
18,096.80
(
0.10%
)
Dow Jones
39,869.38
(
-0.10%
)
Brent Oil
83.04
(
-0.20%
)
Bitcoin
66,250.00
(
1.55%
)
Post# of 251838
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RNsidersbuying

Send PM Follow Ignore
Followers 46
Posts 4459
Boards Moderated 0
Alias Born 07/26/2010

RNsidersbuying

Re: vinmantoo post# 240667

Monday, 12/06/2021 5:55:10 PM

Monday, December 06, 2021 5:55:10 PM

Post# of 251838
From the NEJM link:

...The efficacy in preventing severe disease was 98.2% (95% CI, 92.8 to 99.6), with 2 cases in the mRNA-1273 group and 106 in the placebo group...

...A total of 32 deaths had occurred by completion of the blinded phase, with 16 deaths each (0.1%) in the placebo and mRNA-1273 groups; no deaths were considered to be related to injections of placebo or vaccine, and 4 were attributed to Covid-19 (3 in the placebo group and 1 in the mRNA-1273 group) (Tables S19 and S26)...

Did 103 "severe disease" cases in the placebo group fully recover or am I in confusion over specific dates??

https://www.nejm.org/doi/10.1056/NEJMoa2113017


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up